文献速递神经核医学肿瘤 PET/CT

血浆磷酸化tau标志物与18F-FDG PET低代谢的体素水平关联研究

Plasma phosphorylated tau biomarkers map onto [^18F]FDG PET hypometabolism: a voxel-wise study in a clinical cohort with CSF-confirmed AD subgroup analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-05-27

结果显示血浆p-tau181/Aβ42与18F-FDG低代谢关联最稳健,全队列主要累及双侧腹侧颞叶/梭状回,脑脊液确诊AD亚组(n=58)累及颞叶/颞边缘及后皮质区。

要点

  • 血浆p-tau181/Aβ42与18F-FDG低代谢的体素关联最稳健且空间一致。
  • 全队列关联主要位于双侧腹侧颞叶/梭状回。
  • 脑脊液确诊AD亚组关联位于颞叶/颞边缘及后皮质区。

核心结论

  • 小脑归一化后,血浆p-tau181/Aβ42与18F-FDG PET低代谢关联最稳健。
  • 血浆tau标志物与18F-FDG PET提供互补的分子与代谢信息。

研究设计与样本

  • 图像经空间标准化和平滑后,逐体素除以基于AAL3小脑区的受试者特异性双侧小脑参考值。
  • 采用体素水平多元回归检验血浆Aβ42/Aβ40、p-tau181、p-tau181/Aβ42、p-tau217及p-tau217/Aβ42的关联,校正年龄和性别。
  • 分析在全队列及脑脊液确诊AD亚组(n=58)中进行。

主要发现

  • 全队列中,血浆p-tau181和p-tau181/Aβ42与小脑归一化18F-FDG摄取呈负关联,主要位于双侧腹侧颞叶/梭状回。
  • 全队列中p-tau181/Aβ42关联最强且空间最一致,血浆Aβ42/Aβ40和p-tau217无超阈值关联,p-tau217/Aβ42仅见小灶性簇。
  • 脑脊液确诊AD亚组中,p-tau181/Aβ42仍为最一致的tau相关标志物,与颞叶/颞边缘及后皮质区小脑归一化18F-FDG摄取呈负关联。
  • 脑脊液确诊AD亚组中,p-tau217和p-tau217/Aβ42无超阈值簇。

关键数值与推荐

  • 全队列分析校正年龄和性别,检验五种血浆标志物与体素水平小脑归一化18F-FDG摄取的关联。
  • 脑脊液确诊AD亚组n=58,同样校正年龄和性别进行体素水平分析。

临床怎么用

  • 血浆p-tau181/Aβ42可作为与18F-FDG PET低代谢空间模式相关的血液标志物参考。
  • 血浆tau标志物与18F-FDG PET信息互补,可结合用于认知障碍的分子与代谢评估。

局限性

  • 全队列关联异质性可能部分反映AD与非AD的生物学分离。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine voxel-wise associations between plasma phosphorylated tau biomarkers and cerebellum-normalised [^18F]fluorodeoxyglucose ([^18F]FDG) positron emission tomography (PET) uptake in cognitively impaired patients, and whether these associations persist in a cerebrospinal fluid (CSF)-confirmed Alzheimer's disease (AD) subgroup. METHODS: One hundred consecutive patients who underwent brain [^18F]FDG PET and plasma biomarker assessment within ≤ 6 months were included. Images were spatially normalised, smoothed, and divided voxel-wise by a subject-specific bilateral cerebellar reference value derived from Automated Anatomical Labelling 3 (AAL3) cerebellar regions. Voxel-wise multiple regressions tested associations with plasma Aβ42/Aβ40, p-tau181, p-tau181/Aβ42, p-tau217, and p-tau217/Aβ42, adjusting for age and sex, in the full cohort and the CSF-confirmed AD subgroup (n = 58). RESULTS: In the full cohort, plasma p-tau181 and p-tau181/Aβ42 showed negative associations with cerebellum-normalised [^18F]FDG uptake, predominantly in bilateral ventral temporal/fusiform regions. The strongest and most spatially consistent finding involved p-tau181/Aβ42. Plasma Aβ42/Aβ40 and p-tau217 showed no suprathreshold associations, whereas p-tau217/Aβ42 showed only a small focal cluster. In the CSF-confirmed AD subgroup, p-tau181/Aβ42 remained the most consistent tau-related marker, showing negative associations with cerebellum-normalised [^18F]FDG uptake in temporal/temporo-limbic and posterior cortical regions, whereas p-tau217 and p-tau217/Aβ42 showed no suprathreshold clusters. CONCLUSIONS: After voxel-wise cerebellar normalisation, plasma p-tau181/Aβ42 showed the most robust association with [^18F]FDG PET hypometabolism, predominantly involving bilateral ventral temporal/fusiform regions in the full cohort and temporal/temporo-limbic and posterior cortical regions in the CSF-confirmed AD subgroup. The heterogeneous full-cohort findings may partly reflect AD-versus-non-AD biological separation. Overall, plasma tau biomarkers and [^18F]FDG PET provide complementary molecular and metabolic information.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chiaravalloti A, Motta C, Bonomi CG, et al. Plasma phosphorylated tau biomarkers map onto [^18F]FDG PET hypometabolism: a voxel-wise study in a clinical cohort with CSF-confirmed AD subgroup analysis. Eur J Nucl Med Mol Imaging. 2026. PMID: 42191948. doi:10.1007/s00259-026-07939-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。